143 related articles for article (PubMed ID: 3464435)
1. Cefmenoxime kinetics during continuous ambulatory peritoneal dialysis.
Sica DA; Polk RE; Kerkering TM; Patterson P; Baggett J
Eur J Clin Pharmacol; 1986; 30(6):713-7. PubMed ID: 3464435
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of intravenous and intraperitoneal cefotaxime in chronic ambulatory peritoneal dialysis.
Albin HC; Demotes-Mainard FM; Bouchet JL; Vincon GA; Martin-Dupont C
Clin Pharmacol Ther; 1985 Sep; 38(3):285-9. PubMed ID: 4028623
[TBL] [Abstract][Full Text] [Related]
3. Cefmenoxime pharmacokinetics in patients with renal insufficiency.
Polk RE; Sica DA; Kerkering TM; Kline BJ; Patterson PM; Baggett JW
Antimicrob Agents Chemother; 1984 Sep; 26(3):322-7. PubMed ID: 6095752
[TBL] [Abstract][Full Text] [Related]
4. Cefmenoxime pharmacokinetics in healthy volunteers and subjects with renal insufficiency and on hemodialysis.
Gambertoglio JG; Alexander DP; Barriere SL
Antimicrob Agents Chemother; 1984 Dec; 26(6):845-9. PubMed ID: 6098220
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of intravenous ceftizoxime in patients on continuous ambulatory peritoneal dialysis.
Johnson CA; Zimmerman SW; Bayer W; Craig WA
Clin Nephrol; 1985 Mar; 23(3):120-4. PubMed ID: 3857136
[TBL] [Abstract][Full Text] [Related]
6. Disposition of cefotaxime and desacetyl cefotaxime during continuous ambulatory peritoneal dialysis.
Heim KL; Halstenson CE; Comty CM; Affrime MB; Matzke GR
Antimicrob Agents Chemother; 1986 Jul; 30(1):15-9. PubMed ID: 3752976
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of ceftizoxime in patients undergoing continuous ambulatory peritoneal dialysis.
Burgess ED; Blair AD
Antimicrob Agents Chemother; 1983 Aug; 24(2):237-9. PubMed ID: 6314887
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of intravenous and intraperitoneal moxalactam in chronic ambulatory peritoneal dialysis.
Albin H; Ragnaud JM; Demotes-Mainard F; Vincon G; Wone C
Eur J Clin Pharmacol; 1986; 30(3):299-302. PubMed ID: 3732364
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of cefotaxime in patients undergoing haemodialysis and continuous ambulatory peritoneal dialysis.
Hasegawa H; Imada A; Horiuchi A; Nishii Y; Fukushima M; Kurokawa E
J Antimicrob Chemother; 1984 Sep; 14 Suppl B():135-42. PubMed ID: 6094432
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic study of cefmenoxime (SCE 1365-CMX) in healthy adults.
Fourtillan JB; Bryskier A; Mignot A; Borsa F; Humbert G
Am J Med; 1984 Dec; 77(6A):28-31. PubMed ID: 6097120
[TBL] [Abstract][Full Text] [Related]
11. Ceftizoxime elimination kinetics in continuous ambulatory peritoneal dialysis.
Gross ML; Somani P; Ribner BS; Raeader R; Freimer EH; Higgins JT
Clin Pharmacol Ther; 1983 Nov; 34(5):673-80. PubMed ID: 6313276
[TBL] [Abstract][Full Text] [Related]
12. Effect of probenecid on the pharmacokinetics of cefmenoxime.
Sennello LT; Quinn D; Rollins DE; Tolman KG; Sonders RC
Antimicrob Agents Chemother; 1983 Jun; 23(6):803-7. PubMed ID: 6311084
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of cefmenoxime in patients with impaired renal function and in those undergoing hemodialysis.
Konishi K
Antimicrob Agents Chemother; 1986 Dec; 30(6):901-5. PubMed ID: 3468882
[TBL] [Abstract][Full Text] [Related]
14. Effect of protein binding on cefmenoxime steady-state kinetics in critical patients.
Reitberg DP; Cumbo TJ; Smith IL; Schentag JJ
Clin Pharmacol Ther; 1984 Jan; 35(1):64-73. PubMed ID: 6317272
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic studies of cefoxitin in continuous ambulatory peritoneal dialysis.
Arvidsson A; Alván G; Tranaeus A; Malmborg AS
Eur J Clin Pharmacol; 1985; 28(3):333-7. PubMed ID: 4007038
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacokinetics of cefmenoxime in the aged subject (60 to 90 years of age) after an intravenous injection of 1 g].
Veyssier P; Bryskier A; Modai J; Boquet A; Fourtillan JB
Pathol Biol (Paris); 1986 Dec; 34(10):1081-3. PubMed ID: 3547264
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of cefodizime during continuous ambulatory peritoneal dialysis.
Mendes P; Lameire N; Rosenkranz B; Malerczyk V; Damm D
J Antimicrob Chemother; 1990 Nov; 26 Suppl C():89-93. PubMed ID: 2074257
[TBL] [Abstract][Full Text] [Related]
18. Intramuscular and intravenous pharmacokinetics of cefmenoxime, a new broad-spectrum cephalosporin, in healthy subjects.
Granneman GR; Sennello LT; Steinberg FJ; Sonders RC
Antimicrob Agents Chemother; 1982 Jan; 21(1):141-5. PubMed ID: 6282203
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of vancomycin in patients undergoing continuous ambulatory peritoneal dialysis.
Blevins RD; Halstenson CE; Salem NG; Matzke GR
Antimicrob Agents Chemother; 1984 May; 25(5):603-6. PubMed ID: 6732227
[TBL] [Abstract][Full Text] [Related]
20. Disposition kinetics of cefamandole during continuous ambulatory peritoneal dialysis.
Bliss M; Mayersohn M; Arnold T; Logan J; Michael UF; Jones W
Antimicrob Agents Chemother; 1986 Apr; 29(4):649-53. PubMed ID: 3707113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
